Moneycontrol PRO
HomeNewsIndiaPM Narendra Modi to interact with Varanasi’s COVID-19 vaccine beneficiaries: Here is what to expect

PM Narendra Modi to interact with Varanasi’s COVID-19 vaccine beneficiaries: Here is what to expect

PM Narendra Modi's interaction with COVID-19 beneficiaries and vaccinators comes at a time when some have shown hesitation towards getting vaccinated.

January 22, 2021 / 11:12 IST
File image: Prime Minister Narendra Modi addressing the nation while launching the COVID-19 vaccination drive (Image: YouTube/Narendra Modi)

Prime Minister Narendra Modi will interact with COVID-19 vaccine beneficiaries and vaccinators in his Lok Sabha constituency of Varanasi, Uttar Pradesh on January 22 via video conferencing.

Starting 1.15 pm, participants will share their experience of vaccination with the prime minister.

"This interaction would give first hand opportunity to hear their experiences as well as feedback. I would urge you all to watch tomorrow’s interaction," PM Modi said in a tweet.

The interaction comes at a time when some beneficiaries have shown hesitation to getting vaccinated citing one of the vaccine’s efficacy data and due to other rumours of the jabs being unsafe. The data was also questioned by some experts. The Centre and state governments are scrambling to increase awareness about the vaccines.

Follow our LIVE blog for the latest updates of the coronavirus pandemic

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

PM Modi, while launching the “world’s largest” vaccination drive on January 16, asked people to be aware of propaganda and rumours about the efficacy of the COVID-19 vaccines that have been approved for public use in India.

“Our Indian scientists and experts have guaranteed the safety of the vaccine, so the people of the country must not listen to any kind of propaganda and rumours surrounding the COVID-19 vaccine,” PM Modi said.

Healthcare workers feel used as ‘guinea pigs’, hesitate to take Covaxin

The Drugs Controller General of India (DCGI) has approved two vaccines – Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin – for restricted emergency use. Beneficiaries will not be able to choose between the two jabs. Covaxin is still in the phase-3 clinical trial.

COVID-19 Vaccine Tracker: All you need to know about manufacturing and pricing

Priority is being given to healthcare and frontline workers, who had already been registered on the purpose-built CoWIN application. This would be sequentially followed by people with comorbidities, senior citizens and finally, the general public. The Centre is hoping to vaccinate 30 crore people by July, in a bid to stop the novel coronavirus pandemic.

As of January 22, India had reported more than 1.06 crore confirmed COVID-19 cases. The death toll from the outbreak in the country stood at over 1.53 lakh. While more than 1.02 crore patients had recovered, 1.88 lakh cases remained ‘active’. Globally, more than 9.73 crore individuals have been infected by the virus and over 20.90 lakh people have died so far.

A speedy rollout of vaccines is being seen as the best way to curb the spread of COVID-19 and restore normalcy in the pandemic-battered global economy. Several countries have already vaccinated a significant number of people from high-risk groups.

Click here for Moneycontrol’s full coverage of the coronavirus pandemic

Moneycontrol News
first published: Jan 22, 2021 11:12 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347